Mu-Sheng Zeng
Virologist who mapped how Epstein-Barr virus drives nasopharyngeal cancer and is developing vaccines against it.
Mu-Sheng Zeng directs the State Key Laboratory of Oncology in South China; his group identified high-risk EBV subtypes linked to nasopharyngeal carcinoma and works on EBV entry mechanisms and vaccine candidates.
| Title | Journal | Year |
|---|---|---|
| Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma | Nature Genetics | 2019 |
Pages like this
not linked directly; found by shared links- IdeaBlood EBV DNA screening for nasopharyngeal cancer across southern China and Southeast Asia
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
- PersonJun Ma
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
- IdeaCatch-up HPV vaccination for men to prevent throat cancer
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
- TrialJUPITER-02
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
- PersonDenise A. Galloway
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based delivery
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
- TrialRTOG 0129 (HPV analysis)
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
- PersonWenfeng Fang
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.